Rekvina Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 ,inter alia, to consider and approve Unaudited Standalone Financial ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Rekvina Laboratories Ltd (formerly Pulsar International Limited, scrip code 526075) has informed BSE that its Board of Directors will meet on 12th August 2025 to consider and approve the Unaudited Standalone Financial Results under Ind AS for the quarter ended 30th June 2025 (Q1 FY26). The filing is made in compliance with SEBI LODR Regulation 29. The company has also closed its trading window from 1st July 2025 until 48 hours after the results are made public, in line with insider trading rules. No financial figures or business details are disclosed in this intimation.
This is a routine advance intimation with no material impact on the stock. Investors should watch for the actual Q1 FY26 results on or after 12th August 2025 for any meaningful signals on revenue, profitability, or margins. The trading window closure is standard regulatory practice and does not indicate positive or negative news by itself.